Complete financial analysis of NewAge, Inc. (NBEV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NewAge, Inc., a leading company in the Beverages – Non-Alcoholic industry within the Consumer Defensive sector.
- Ind-Swift Laboratories Limited (INDSWFTLAB.BO) Income Statement Analysis – Financial Results
- Lonking Holdings Limited (LONKF) Income Statement Analysis – Financial Results
- China Art Financial Holdings Limited (CHFHF) Income Statement Analysis – Financial Results
- CSS Holdings,Ltd. (2304.T) Income Statement Analysis – Financial Results
- PT Phapros, Tbk (PEHA.JK) Income Statement Analysis – Financial Results
NewAge, Inc. (NBEV)
About NewAge, Inc.
NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally. The company operates in two segments, Direct / Social Selling and Direct Store. It provides health and wellness, energy drink, essential oil and anti-aging skincare, cosmetic, beverage, snacks, water and air filtration, and personal care products, as well as weight management, nutritional supplement, nutraceutical, and slenderiize products; diagnostic products, such as DNA testing and diagnostic kits and products; and CBD products. The company offers its products under the Tahitian Noni, LIMU, Zennoa, LIMU Blue Frog, Hiro Natural, TeMana, Lucim, Reviive, Puritii, and MaVie brands. It sells its products directly to customers, as well as through distributors, e-commerce sites, and direct-store-delivery systems. The company was formerly known as New Age Beverages Corporation and changed its name to NewAge, Inc. in July 2020. NewAge, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado. On August 30, 2022, NewAge, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 279.47M | 253.71M | 52.16M | 52.19M | 25.30M | 0.00 | 1.04M | 968.94K |
| Cost of Revenue | 101.98M | 101.00M | 42.87M | 39.79M | 19.51M | 0.00 | 879.46K | 684.59K |
| Gross Profit | 177.49M | 152.71M | 9.30M | 12.40M | 5.80M | 0.00 | 164.19K | 284.35K |
| Gross Profit Ratio | 63.51% | 60.19% | 17.82% | 23.76% | 22.91% | 0.00% | 15.73% | 29.35% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 113.21M | 0.00 | 20.29M | 14.61M | 7.84M | 0.00 | 1.28M | 415.09K |
| Selling & Marketing | 0.00 | 0.00 | 2.78M | 3.84M | 1.58M | 0.00 | 155.98K | 174.01K |
| SG&A | 113.21M | 0.00 | 23.07M | 18.45M | 9.42M | 0.00 | 1.44M | 589.11K |
| Other Expenses | 99.13M | 199.33M | 2.31M | 668.05M | 1.47M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 212.34M | 199.33M | 25.38M | 18.45M | 9.42M | 0.00 | 1.44M | 589.11K |
| Cost & Expenses | 314.32M | 300.33M | 68.24M | 58.24M | 28.93M | 0.00 | 2.32M | 1.27M |
| Interest Income | 0.00 | -227.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.38M | 3.90M | 1.07M | 228.04K | 299.08K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.93M | 8.76M | 2.31M | 1.61M | 523.75K | 77.82K | 169.40K | 103.21K |
| EBITDA | -29.93M | -64.50M | -17.68M | -1.70M | -2.81M | 0.00 | -1.08M | -227.14K |
| EBITDA Ratio | -10.71% | -25.42% | -33.90% | -3.26% | -11.11% | 0.00% | -103.52% | -23.44% |
| Operating Income | -34.85M | -80.00M | -19.37M | -6.05M | -3.63M | 0.00 | -1.28M | -304.75K |
| Operating Income Ratio | -12.47% | -31.53% | -37.14% | -11.59% | -14.33% | 0.00% | -122.27% | -31.45% |
| Total Other Income/Expenses | -2.60M | -98.17M | -1.69M | 2.51M | -6.32K | 0.00 | 26.32K | -25.59K |
| Income Before Tax | -37.45M | -77.17M | -21.06M | -3.54M | -3.63M | 0.00 | -1.25M | -330.34K |
| Income Before Tax Ratio | -13.40% | -30.42% | -40.38% | -6.78% | -14.36% | 0.00% | -119.75% | -34.09% |
| Income Tax Expense | -1.90M | 12.67M | -8.93M | 2.74M | 292.76K | 0.00 | 26.32K | -25.59K |
| Net Income | -39.34M | -89.84M | -12.14M | -3.54M | -3.63M | 0.00 | -1.25M | -330.34K |
| Net Income Ratio | -14.08% | -35.41% | -23.26% | -6.78% | -14.36% | 0.00% | -119.75% | -34.09% |
| EPS | -0.41 | -1.16 | -0.26 | -0.12 | -0.19 | 0.00 | -0.10 | -0.03 |
| EPS Diluted | -0.41 | -1.16 | -0.26 | -0.12 | -0.19 | 0.00 | -0.10 | -0.03 |
| Weighted Avg Shares Out | 96.35M | 77.25M | 46.45M | 30.62M | 18.89M | 18.89M | 12.39M | 12.56M |
| Weighted Avg Shares Out (Dil) | 96.35M | 77.25M | 46.45M | 30.62M | 18.89M | 18.89M | 12.39M | 12.56M |
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NewAge, Inc. (NBEV; NBEVQ) Investors of Class Action and to Actively Participate
Bronstein, Gewirtz & Grossman, LLC Notifies NewAge, Inc. (NBEV; NBEVQ) Investors of Class Action and to Actively Participate
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of NewAge, Inc. Investors – NBEV, NBEVQ
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages NewAge, Inc. Investors to Inquire About Securities Class Action Investigation – NBEVQ, NBEV
Former CEO of NewAge, a drink company that shot to pot-stock fame, accused by SEC of ‘multi-year fraud'
7 Penny Stocks That Actually Have a Buy Rating
Hot Penny Stocks to Buy After the Long Weekend? 3 to Watch
Which Strategies Are You Using With Penny Stocks in September?
7 Penny Stocks to Sell Before They Go to Zero
Trending Penny Stocks to Buy in September? 3 For Your List
Source: https://incomestatements.info
Category: Stock Reports